Luke S. P. Moore, Infectious Diseases Physician and Clinical Microbiologist on behalf of the Healthcare Infection Society, directs our thoughts to optimising our control of infections and looks forward to the post-pandemic period.
Dr Quinton Fivelman, PhD, Chief Scientific Officer at London Medical Laboratory, reveals that antibody levels for the double-jabbed are now waning. He asks was the UK Government unwise to relax most COVID precautions in July?.
Chris Lynch, Deputy CEO at Alzheimer’s Disease International, sheds light on the WHO Global action plan on the public health response to dementia 2017-2025.
Andrew Brodbelt, Consultant Neurosurgeon at The Walton Centre NHS Foundation Trust, describes what we need to know about brain tumour diagnosis & therapy.
Professor Andrew Boulton, President & Professor Akhtar Hussain, President-Elect of the International Diabetes Federation, argue that while there has been a century of saving lives, more must be done to tackle diabetes.
Five new COVID-19 research projects will study the durability of vaccine responses, low responses linked with health conditions and the effect of booster shots.
The UK Government has signed a contract for 35 million more doses of the Pfizer/BioNTech COVID-19 vaccine, to be delivered from the second half of 2022..
Jorge E Palacios, MD, PhD, Senior Digital Health Scientist at SilverCloud Health, argues that the pandemic has made mental health in the workplace impossible to ignore.
Angie Fyfe, Executive Director of ICLEI – Local Governments for Sustainability USA, discusses how thousands of stakeholders are mobilising ahead of COP26.
NHS GP and lead GP at Numan, Dr Luke Pratsides tells us everything he knows about the symptoms of long COVID and what’s being done to tackle this novel disease.
Climate change is behind all of the great humanitarian challenges. We must do more to combat it, argues Aamir Mumtaz, Water, Sanitation and Hygiene Programme Manager at Human Appeal Pakistan.
